genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
lilly
Drug Discovery
Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs
Drug Discovery
Lilly to Acquire DICE for $2.4B, Expanding Immunology Pipeline
News
Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics
Cancer
Seattle and Millennium Report 75% Response Rate in Pivotal ADC Hodgkin Lymphoma Trial
Cancer
Eisai and Quintiles to Jointly Develop Six Eisai Anticancer Agents
Drug Discovery
Transave and NIAID to Evaluate Antibiotic for Nontuberculous Mycobacteria Lung Infections
News
Kythera Raises $30M to Advance Fat-Reduction Compound
Scroll Up
Scroll Up
